{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:34:13Z","timestamp":1784666053687,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12957-016-0804-x","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T04:46:48Z","timestamp":1456289208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Nikolaos","family":"Vassos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"F\u00f6rtsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archil","family":"Aladashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Hohenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland S.","family":"Croner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,24]]},"reference":[{"key":"804_CR1","first-page":"164","volume":"76","author":"FN Gilly","year":"1991","unstructured":"Gilly FN, Sayag AC, Carry PY, et al. Intra-peritoneal chemo-hyperthermia (CHIP): a new therapy in the treatment of the peritoneal seedings Preliminary report. Int Surg. 1991;76:164\u20137.","journal-title":"Int Surg"},{"key":"804_CR2","volume-title":"Technical handbook for the integration of cytoreductive surgery and perioperative intraperitoneal chemotherapy into the surgical management of gastrointestinal and gynecologic malignancy","author":"PH Sugarbaker","year":"2005","unstructured":"Sugarbaker PH. Technical handbook for the integration of cytoreductive surgery and perioperative intraperitoneal chemotherapy into the surgical management of gastrointestinal and gynecologic malignancy. 4th ed. Grand Rapids: The Ludann Company; 2005.","edition":"4"},{"key":"804_CR3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4613-1245-1_13","volume":"81","author":"PH Sugarbaker","year":"1996","unstructured":"Sugarbaker PH. Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy. Cancer Treat Res. 1996;81:149\u201368.","journal-title":"Cancer Treat Res"},{"key":"804_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1470-2045(04)01425-1","volume":"5","author":"O Glehen","year":"2004","unstructured":"Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol. 2004;5:219\u201328.","journal-title":"Lancet Oncol"},{"key":"804_CR5","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","volume":"17","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Arvieux C, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17:2370.","journal-title":"Ann Surg Oncol"},{"key":"804_CR6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1245\/s10434-006-9182-x","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Black D, Savady R, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2007;14:484\u201392.","journal-title":"Ann Surg Oncol"},{"key":"804_CR7","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O. Cytoreductive surgery combined with peritoperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multiinstitutional study. J Clin Oncol. 2004;22:3284\u201392.","journal-title":"J Clin Oncol"},{"key":"804_CR8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.23553","volume":"113","author":"A Giorgio","year":"2008","unstructured":"Giorgio A, Naticchion E, Biacchi D. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer. 2008;113:315\u201325.","journal-title":"Cancer"},{"key":"804_CR9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1525-1438.2006.00314.x","volume":"16","author":"JH Nam","year":"2006","unstructured":"Nam JH, Kim YM, Jung MH, Kim KR, Yoo HJ, Kim DY. Primary peritoneal carcinoma: experience with cytoreductive surgery and combination chemotherapy. Int J Gynecol Cancer. 2006;16:23\u20138.","journal-title":"Int J Gynecol Cancer"},{"key":"804_CR10","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D. Cytoreducive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237\u201342.","journal-title":"J Clin Oncol"},{"key":"804_CR11","first-page":"231","volume":"29","author":"A Saxena","year":"2013","unstructured":"Saxena A, Morris DL. Mortality and morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and peritoneal carcinomatosis. Viszeralmedizin - Gastrointest Med Surg. 2013;29:231\u20134.","journal-title":"Viszeralmedizin - Gastrointest Med Surg"},{"key":"804_CR12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-7819-7-5","volume":"7","author":"G Glockzin","year":"2009","unstructured":"Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009;7:5.","journal-title":"World J Surg Oncol"},{"key":"804_CR13","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/bjs.6235","volume":"95","author":"D Elias","year":"2008","unstructured":"Elias D, Honore C, Ciuchendea R, et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg. 2008;95:1164\u201371.","journal-title":"Br J Surg"},{"key":"804_CR14","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449\u201356.","journal-title":"J Clin Oncol"},{"key":"804_CR15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1245\/s10434-007-9678-z","volume":"15","author":"RP McQuellon","year":"2008","unstructured":"McQuellon RP, Russell GB, Shen P, et al. Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin. Ann Surg Oncol. 2008;15:125\u201333.","journal-title":"Ann Surg Oncol"},{"key":"804_CR16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jamcollsurg.2009.04.019","volume":"209","author":"C Omohwo","year":"2009","unstructured":"Omohwo C, Nieroda CA, Gushchin V, et al. Complete cytoreduction offers longterm survival in patients with paritoneal carcinomatosis from appendiceal tumors of unfavorable histology. J Am Coll Surg. 2009;209:308\u201312.","journal-title":"J Am Coll Surg"},{"key":"804_CR17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681\u20135.","journal-title":"J Clin Oncol"},{"key":"804_CR18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejso.2010.10.014","volume":"37","author":"F Cavaliere","year":"2011","unstructured":"Cavaliere F, De Simone M, Virzi S, et al. Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol. 2011;37:148\u201354.","journal-title":"Eur J Surg Oncol"},{"key":"804_CR19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.amjsurg.2011.02.004","volume":"202","author":"EN Parson","year":"2011","unstructured":"Parson EN, Lentz S, Russell G, et al. Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms. Am J Surg. 2011;202:481\u201386.","journal-title":"Am J Surg"},{"key":"804_CR20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jso.21682","volume":"102","author":"F Roviello","year":"2010","unstructured":"Roviello F, Pinto E, Corso G, et al. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer. J Surg Oncol. 2010;102:663\u201370.","journal-title":"J Surg Oncol"},{"key":"804_CR21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl428","volume":"18","author":"TD Yan","year":"2007","unstructured":"Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007;18:827\u201334.","journal-title":"Ann Oncol"},{"key":"804_CR22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0399-8320(07)73964-7","volume":"31","author":"D Elias","year":"2007","unstructured":"Elias D, Bedard V, Bouzid T, Duvillard P, Kohneh-Sharhi N, Raynard B. Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy. Gastroenterol Clin Biol. 2007;31:784\u20138.","journal-title":"Gastroenterol Clin Biol"},{"key":"804_CR23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1245\/ASO.2004.08.014","volume":"11","author":"VJ Verwaal","year":"2004","unstructured":"Verwaal VJ, Boot H, Aleman BM, et al. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome. Ann Surg Oncol. 2004;11:375\u20139.","journal-title":"Ann Surg Oncol"},{"key":"804_CR24","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1245\/s10434-009-0611-5","volume":"16","author":"A Brouquet","year":"2009","unstructured":"Brouquet A, Go\u00e9r\u00e9 D, Lef\u00e8vre JH, Bonnet S, Dumont F, Raynard B, et al. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome. Ann Surg Oncol. 2009;16:2744\u201351.","journal-title":"Ann Surg Oncol"},{"key":"804_CR25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.sla.0000231705.40081.1a","volume":"245","author":"RM Smeenk","year":"2007","unstructured":"Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007;245:104\u20139.","journal-title":"Ann Surg"},{"key":"804_CR26","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1245\/s10434-007-9462-0","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Bijelic L, Sugarbaker PH. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol. 2007;14:2289\u201399.","journal-title":"Ann Surg Oncol"},{"key":"804_CR27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jamcollsurg.2012.04.023","volume":"215","author":"KI Votanopoulos","year":"2012","unstructured":"Votanopoulos KI, Ihemelandu C, Shen P, et al. Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. J Am Coll Surg. 2012;215:412\u20137.","journal-title":"J Am Coll Surg"},{"key":"804_CR28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1245\/ASO.2006.03.045","volume":"13","author":"M Deraco","year":"2006","unstructured":"Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol. 2006;13:229\u201337.","journal-title":"Ann Surg Oncol"},{"key":"804_CR29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29\u201342.","journal-title":"Ann Surg"},{"key":"804_CR30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavein PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201321.","journal-title":"Ann Surg"},{"key":"804_CR31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s002689900560","volume":"23","author":"AG Portilla","year":"1999","unstructured":"Portilla AG, Sugarbaker PH, Chang D. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J Surg. 1999;23:23\u20139.","journal-title":"World J Surg"},{"key":"804_CR32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00000658-200108000-00009","volume":"234","author":"J Esquivel","year":"2001","unstructured":"Esquivel J, Sugarbaker PH. Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients. Ann Surg. 2001;234:198\u2013205.","journal-title":"Ann Surg"},{"key":"804_CR33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jso.23062","volume":"106","author":"N Golse","year":"2012","unstructured":"Golse N, Bakrin N, Passot G, et al. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results. J Surg Oncol. 2012;106:197\u2013203.","journal-title":"J Surg Oncol"},{"key":"804_CR34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/01.sla.0000255561.87771.11","volume":"245","author":"R Kianmanesh","year":"2007","unstructured":"Kianmanesh R, Scaringi S, Sabate JM, Castel B, Pons-Kerjean N, Coffin B. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg. 2007;245:597\u2013603.","journal-title":"Ann Surg"},{"key":"804_CR35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/jso.23356","volume":"108","author":"TC Chua","year":"2013","unstructured":"Chua TC, Quinn LE, Zhao J, Morris DL. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases. J Surg Oncol. 2013;108:81\u20138.","journal-title":"J Surg Oncol"},{"key":"804_CR36","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1245\/s10434-013-3341-7","volume":"21","author":"J Wong","year":"2014","unstructured":"Wong J, Koch AL, Deneve JL, Fulp W, Tanvetyanon T, Dessureault S. Repeat cytoreductive surgery and heated intraperitoneal chemotherapy may offer survival benefit for intraperitoneal mesothelioma: a single institution experience. Ann Surg Oncol. 2014;21:1480\u20136.","journal-title":"Ann Surg Oncol"},{"key":"804_CR37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ejso.2013.08.017","volume":"39","author":"A Sardi","year":"2013","unstructured":"Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes. Eur J Surg Oncol. 2013;39:1207\u201313.","journal-title":"Eur J Surg Oncol"},{"key":"804_CR38","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1245\/s10434-014-3977-y","volume":"22","author":"C Ihemelandu","year":"2015","unstructured":"Ihemelandu C, Bijelic L, Sugarbaker PH. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome. Ann Surg Oncol. 2015;22:1680\u20135.","journal-title":"Ann Surg Oncol"},{"key":"804_CR39","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1007\/s00268-015-2986-8","volume":"39","author":"JF Wong","year":"2015","unstructured":"Wong JF, Tan GH, Wang W, Soo KC, Teo MC. Repeat cytoreductive surgery and HIPEC for peritoneal surface malignancy and peritoneal carcinomatosis. World J Surg. 2015;39:1578\u201383.","journal-title":"World J Surg"},{"key":"804_CR40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3109\/02656736.2014.974693","volume":"30","author":"M Vaira","year":"2014","unstructured":"Vaira M, Robella M, Mellano A, Sottile A, De Simone M. Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence. Int J Hyperthermia. 2014;30:565\u20139.","journal-title":"Int J Hyperthermia"},{"key":"804_CR41","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0399-8320(06)73537-0","volume":"30","author":"J Lubrano","year":"2006","unstructured":"Lubrano J, Huet E, Foulatier O, Michel P, Michot F, T\u00e9ni\u00e8re P, et al. Intraperitoneal hyperthermic chemotherapy in the management of recurrent peritoneal carcinomatosis. Preliminary results in 5 patients. Gastroenterol Clin Biol. 2006;30:1297\u2013300.","journal-title":"Gastroenterol Clin Biol"},{"key":"804_CR42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejso.2009.06.008","volume":"36","author":"A Saxena","year":"2010","unstructured":"Saxena A, Yan TD, Morris DL. Critical assessment of preoperative and opertive risk factors for complications after iterative peritonectomy procedures. Eur J Surg Oncol. 2010;36:309\u201314.","journal-title":"Eur J Surg Oncol"},{"key":"804_CR43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jso.21084","volume":"98","author":"L Bijelic","year":"2008","unstructured":"Bijelic L, Yan TD, Sugarbaker PH. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms. J Surg Oncol. 2008;98:295\u20139.","journal-title":"J Surg Oncol"},{"key":"804_CR44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jso.10234","volume":"83","author":"F Mohamed","year":"2003","unstructured":"Mohamed F, Chang D, Sugarbaker PH. Third look surgery and beyond for appendiceal malignancy with peritoneal dissemination. J Surg Oncol. 2003;83:5\u201313.","journal-title":"J Surg Oncol"},{"key":"804_CR45","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jso.23189","volume":"107","author":"TC Chua","year":"2013","unstructured":"Chua TC, Esquivel J, Pelz JO, Morris DL. Summary of current therapeutic options for peritoneal metastases from colorectal cancer. J Surg Oncol. 2013;107:566\u201373.","journal-title":"J Surg Oncol"},{"key":"804_CR46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric french study. J Clin Oncol. 2010;28:63\u20138.","journal-title":"J Clin Oncol"},{"key":"804_CR47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1245\/s10434-011-1840-y","volume":"19","author":"H Halabi El","year":"2012","unstructured":"El Halabi H, Gushchin V, MacDonald R, et al. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS\/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol. 2012;19:110\u20134.","journal-title":"Ann Surg Oncol"},{"key":"804_CR48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archsurg.138.1.26","volume":"138","author":"P Shen","year":"2003","unstructured":"Shen P, Levine EA, Hall J, et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg. 2003;138:26\u201333.","journal-title":"Arch Surg"},{"key":"804_CR49","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","volume":"203","author":"RG Silva da","year":"2006","unstructured":"da Silva RG, Sugarbaker PH. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg. 2006;203:878\u201386.","journal-title":"J Am Coll Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-016-0804-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T06:40:10Z","timestamp":1498286410000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjso.com\/content\/14\/1\/42"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,24]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["804"],"URL":"https:\/\/doi.org\/10.1186\/s12957-016-0804-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,24]]},"article-number":"42"}}